170 related articles for article (PubMed ID: 7750207)
1. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.
Wang Y; Dang J; Liang X; Doe WF
Clin Exp Metastasis; 1995 May; 13(3):196-202. PubMed ID: 7750207
[TBL] [Abstract][Full Text] [Related]
2. Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells.
Wang Y; Jones CJ; Dang J; Liang X; Olsen JE; Doe WF
FEBS Lett; 1994 Oct; 353(2):138-42. PubMed ID: 7926038
[TBL] [Abstract][Full Text] [Related]
3. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells.
Dang J; Wang Y; Doe WF
FEBS Lett; 1995 Feb; 359(2-3):147-50. PubMed ID: 7867787
[TBL] [Abstract][Full Text] [Related]
4. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
Antalis TM; Reeder JA
Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
[TBL] [Abstract][Full Text] [Related]
5. Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.
Wang X; Jiang Z; An J; Mao X; Lin F; Sun P
Mol Med Rep; 2018 Mar; 17(3):4273-4280. PubMed ID: 29328476
[TBL] [Abstract][Full Text] [Related]
6. A labile repressor acts through the NFkB-like binding sites of the human urokinase gene.
Novak U; Cocks BG; Hamilton JA
Nucleic Acids Res; 1991 Jun; 19(12):3389-93. PubMed ID: 1905804
[TBL] [Abstract][Full Text] [Related]
7. Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21.
Niiya K; Taniguchi T; Shinbo M; Ishikawa T; Tazawa S; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1994 Jul; 72(1):92-7. PubMed ID: 7974383
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional regulation of urokinase plasminogen activator gene expression occurs in the nucleus of BC1 rat mammary tumor cells.
Henderson BR; McDonald DA; Kefford RF
Int J Cancer; 1992 Apr; 50(6):918-23. PubMed ID: 1555891
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of macrophage urokinase expression by polyanions is protein kinase C-dependent and requires protein and RNA synthesis.
Falcone DJ; McCaffrey TA; Vergilio JA
J Biol Chem; 1991 Nov; 266(33):22726-32. PubMed ID: 1658006
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor.
Gualandris A; Presta M
J Cell Physiol; 1995 Mar; 162(3):400-9. PubMed ID: 7860647
[TBL] [Abstract][Full Text] [Related]
12. C-phycocyanin transcriptionally regulates uPA mRNA through cAMP mediated PKA pathway in human fibroblast WI-38 cells.
Madhyastha HK; Radha KS; Sugiki M; Omura S; Maruyama M
Biochim Biophys Acta; 2006 Nov; 1760(11):1624-30. PubMed ID: 17029796
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy.
Dunn SE; Torres JV; Nihei N; Barrett JC
Mol Carcinog; 2000 Jan; 27(1):10-7. PubMed ID: 10642432
[TBL] [Abstract][Full Text] [Related]
14. Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.
Stoppelli MP; Verde P; Grimaldi G; Locatelli EK; Blasi F
J Cell Biol; 1986 Apr; 102(4):1235-41. PubMed ID: 3958045
[TBL] [Abstract][Full Text] [Related]
15. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
16. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Lund LR
FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
[TBL] [Abstract][Full Text] [Related]
17. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
18. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.
Lund LR; Ellis V; Rønne E; Pyke C; Danø K
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):345-52. PubMed ID: 7646466
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator gene expression is induced by the src oncogene product and tumor promoters.
Bell SM; Brackenbury RW; Leslie ND; Degen JL
J Biol Chem; 1990 Jan; 265(3):1333-8. PubMed ID: 2153128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
